On type 1 diabetes mellitus pathogenesis SA Paschou, N Papadopoulou-Marketou, GP Chrousos, ... Endocrine connections 7 (1), R38-R46, 2018 | 338 | 2018 |
Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis N Papadopoulou‐Marketou, GP Chrousos, C Kanaka‐Gantenbein Diabetes/metabolism research and reviews 33 (2), e2841, 2017 | 292 | 2017 |
Biomarkers of diabetic nephropathy: A 2017 update N Papadopoulou-Marketou, C Kanaka-Gantenbein, N Marketos, ... Critical reviews in clinical laboratory sciences 54 (5), 326-342, 2017 | 157 | 2017 |
Diabetic nephropathy in type 1 diabetes. N Papadopoulou-Marketou, SA Paschou, N Marketos, S Adamidi, ... Minerva medica 109 (3), 218-228, 2017 | 140 | 2017 |
NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up N Papadopoulou-Marketou, C Skevaki, I Kosteria, M Peppa, GP Chrousos, ... Hormones 14, 232-240, 2015 | 66 | 2015 |
The clinical impact of growth differentiation factor-15 in heart disease: A 2019 update M Arkoumani, N Papadopoulou-Marketou, NC Nicolaides, ... Critical reviews in clinical laboratory sciences 57 (2), 114-125, 2020 | 60 | 2020 |
Aldosterone deficiency and resistance K Arai, N Papadopoulou-Marketou, GP Chrousos Endotext [Internet], 2020 | 55 | 2020 |
Overview of endocrine hypertension C Koch, N Papadopoulou-Marketou, GP Chrousos Endotext [Internet], 2020 | 37 | 2020 |
NGAL as an early predictive marker of diabetic nephropathy in children and young adults with type 1 diabetes mellitus N Papadopoulou-Marketou, A Margeli, I Papassotiriou, GP Chrousos, ... Journal of diabetes research 2017 (1), 7526919, 2017 | 37 | 2017 |
Hyperaldosteronism A Vaidya, R Dluhy Endotext [Internet]. South Dartmouth (MA): MDText. com, Inc, 2000 | 31* | 2000 |
Plasma levels of tissue inhibitor of metalloproteinase-1 in patients with type 1 diabetes mellitus associate with early diabetic neuropathy and nephropathy N Papadopoulou-Marketou, PA Whiss, AC Eriksson, L Hyllienmark, ... Diabetes and Vascular Disease Research 18 (2), 14791641211002470, 2021 | 19 | 2021 |
Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms K Daskalakis, E Chatzelis, M Tsoli, N Papadopoulou-Marketou, ... Endocrine 64, 384-392, 2019 | 19 | 2019 |
On type 1 diabetes mellitus pathogenesis. Endocr Connect 7 (1): R38–R46 SA Paschou, N Papadopoulou-Marketou, GP Chrousos, ... | 19 | 2018 |
Ultrasound-guided intra-articular injection: efficacy of hyaluronic acid compared to glucocorticoid in the treatment of knee osteoarthritis S Parisi, M Ditto, M Priora, R Borrelli, A Lagana, CL Peroni, E Fusaro Minerva Medica 110 (6), 515-523, 2019 | 16 | 2019 |
On type 1 diabetes mellitus pathogenesis. Endocr. Connect. 2018; 7: R38–R46. doi: 10.1530 SA Paschou, N Papadopoulou-Marketou, GP Chrousos, ... EC-17-0347.[Europe PMC free article][Abstract][CrossRef][Academic Search], 0 | 16 | |
On type 1 diabetes mellitus pathogenesis. Endocr Connect 2018; 7 (1): R38-46. doi: 10.1530 SA Paschou, N Papadopoulou-Marketou, GP Chrousos, ... EC-17-0347 PMID: 29191919, 0 | 16 | |
Photoplethysmography (PPG)-determined heart rate variability (HRV) and extracellular water (ECW) in the evaluation of chronic stress and inflammation GP Chrousos, N Papadopoulou-Marketou, F Bacopoulou, M Lucafò, ... Hormones, 1-8, 2022 | 13 | 2022 |
Emerging technologies in pediatrics: the paradigm of neonatal diabetes mellitus NC Nicolaides, C Kanaka-Gantenbein, N Papadopoulou-Marketou, ... Critical Reviews in Clinical Laboratory Sciences 57 (8), 522-531, 2020 | 9 | 2020 |
The role of chemokines in type 1 diabetes‐associated neuropathy E Baldimtsi, N Papadopoulou‐Marketou, MC Jenmalm, J Wahlberg Endocrinology, diabetes & metabolism 6 (3), e419, 2023 | 7 | 2023 |
Adrenal androgens and aging N Papadopoulou-Marketou, E Kassi, GP Chrousos Endotext [Internet], 2023 | 7 | 2023 |